Nice to hear from you Respert, The problem with
Post# of 154090
(Total Views: 524)
Posted On: 02/07/2024 6:24:09 PM
Nice to hear from you Respert,
The problem with Ozempic going for weight loss, is all the diabetes patients who really need it. Now it’s being distributed in ‘for profit internet clinics’ along with dick pills and because it’s plant-based and not enough farms produce the plant to supply a world wide demand for prepubescent figures, real patients who actually find it feel as if they won the lottery. I can appreciate the value set with that, but am also happy it goes down the toilet.
I agree that Dr J, not only has several Icon level slam dunks named after him, he also joined Cytodyn at a time when things might move. The thing that concerns me and my average share price is how many overhanging cheap warrants, salary shares, fundraising shares at low prices will liquidate on any rise, and it might take years for my 1.07 ASP to be in the money.
Good luck to y’all.
The problem with Ozempic going for weight loss, is all the diabetes patients who really need it. Now it’s being distributed in ‘for profit internet clinics’ along with dick pills and because it’s plant-based and not enough farms produce the plant to supply a world wide demand for prepubescent figures, real patients who actually find it feel as if they won the lottery. I can appreciate the value set with that, but am also happy it goes down the toilet.
I agree that Dr J, not only has several Icon level slam dunks named after him, he also joined Cytodyn at a time when things might move. The thing that concerns me and my average share price is how many overhanging cheap warrants, salary shares, fundraising shares at low prices will liquidate on any rise, and it might take years for my 1.07 ASP to be in the money.
Good luck to y’all.
(6)
(0)